FridayDec 04, 2020 10:31 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Commercial Launch Date for ImmunaZin(TM)

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of pressure-based instruments, consumables and platform solutions to the worldwide biotechnology and other industries, today announced that its proposed acquisition partner Cannaworx Inc. has set December 2020 as the commercial launch date for its patented immune booster supplement: ImmunaZin(TM). According to the update, Cannaworx believes that post-launch, this product will be one of very few over-the-counter, FDA-registered, hemp seed oil-enhanced supplements with an immune-booster claim. “Our team is excited to be joining a company bringing such an important and valuable product to market, particularly considering its potential role in…

Continue Reading

FridayDec 04, 2020 10:11 am

QualityStocksNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) to Provide QuadSight(R) Solution in Framework for AWARD Project

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced that the European Commission, through the Horizon 2020 framework program, has awarded a funding grant of nearly 20 million Euro for the All Weather Autonomous Real logistics operations and Demonstrations (“AWARD”) consortium to develop and operate safe autonomous heavy-duty vehicles in harsh weather conditions in a variety of different scenarios. As part of the project, Foresight will provide its QuadSight(R) multispectral vision solution, and is expected to receive approximately one million USD. According to the update, the AWARD project will be rolled out in 2021…

Continue Reading

FridayDec 04, 2020 9:40 am

QualityStocksNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Issues Update on Portfolio Companies

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, on Thursday provided an update on three portfolio companies: TerrAscend, YSS and Dynaleo. "Over the past month, our portfolio companies have made several announcements that demonstrate their continued momentum and growth in their respective markets," said Canopy Rivers’ Narbe Alexandrian. "We believe that this growth is a testament to the theses behind these investments, and we look forward to seeing their progress continue into 2021." To view the full press release, visit https://ibn.fm/fZxGl About Canopy Rivers Inc. Canopy Rivers is a venture capital firm specializing in cannabis…

Continue Reading

ThursdayDec 03, 2020 3:24 pm

QualityStocksNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) to Present at LD Micro Main Event

180 Life Sciences (NASDAQ: ATNF, ATNFW), a clinical-stage biotechnology company with its lead indication in phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced that it will participate in the LD Micro Virtual Main Event 2020 Conference. According to the update, 180 Life Sciences CEO Dr. James Woody is scheduled to present at 1:40 p.m. EST on Tuesday, Dec. 15. Interested parties should visit https://ibn.fm/KHrgf to register for the event. The 2020 LD Micro Main Event will feature a new and unique format with companies presenting for 10…

Continue Reading

ThursdayDec 03, 2020 2:06 pm

QualityStocksNewsBreaks – Grey Cloak Tech Inc. (GRCK) Announces Positive Clinical Study Results for ‘HERHEART(TM)’

Grey Cloak Tech (OTCQB: GRCK) (soon to be Healthy Extracts Inc.), a company engaged in proprietary development of natural plant-based formulations and sales and distribution of clinically proven cardiovascular and neuro products, today announced that the newly released clinical study of BergaMet NA’s HERHEART(TM) product produced incredible results. In addition, the company announced the appointment of internationally renowned Dr. Nesochi Okeke-Igokwe MD., M.S to its medical advisory board to promote women’s health. “Cardiovascular disease is the number one cause of death for women in the United States,” said Duke Pitts, CEO of BergaMet NA. “HERHEART was specifically formulated to fill…

Continue Reading

ThursdayDec 03, 2020 1:48 pm

QualityStocksNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) to Exhibit COVID-19 Symptom Detection Solution at Future Stars 2020 Conference

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision, has announced that it will be exhibiting its mass screening COVID-19 symptom detection solution at the GITEX Future Stars 2020 conference and exhibition. Slated for Dec. 6–9, 2020, the conference is held at the Dubai World Trade Centre in the United Arab Emirates and is the largest start-up expo in the Middle East, Africa and South Asia. The event showcases transformational ideas that could significantly impact the government and business sectors. More than 1,200 innovative tech enterprises, start-ups and government entities from more than 60 countries are expected…

Continue Reading

ThursdayDec 03, 2020 1:22 pm

QualityStocksNewsBreaks – CannAssist International Corporation (CNSC) Commences Trading on the OTCQB

CannAssist (OTCQB: CNSC), a unique, enhanced cannabidiol (“CBD”) company, recently commenced trading on the OTC Markets Platform - OTCQB Markets Tier. “Our Team has been working diligently for years to get to where we are now. Third party testing has revealed that our proprietary process used in our products can facilitate enhanced absorbency of CBD and aid in promoting connections with the endocannabinoid receptors that exist within all humans,” said CannAssist CEO and Founder Mark Palumbo. “We are very excited to get to launch our new enhanced CBD product, ‘Xceptol’ and assist as many as possible.” To view the full…

Continue Reading

ThursdayDec 03, 2020 12:49 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Present Overview, Clinical Trial Update at Upcoming Benzinga Conference

Genprex (NASDAQ: GNPX), focused on developing life-changing therapies for patients with cancer and diabetes, today announced that it will present at the Benzinga Global Small Cap Conference taking place virtually on Dec. 8-9, 2020. Genprex’s president and CEO, Rodney Varner, will deliver a company overview that includes recent progress the company has made on its upcoming Acclaim-1 clinical trial. Varner’s presentation is scheduled to begin at 2:30 p.m. EST on Tuesday, Dec. 8. Investors and other interested parties should visit https://ibn.fm/VdFrh to register for the event. To view the full press release, visit https://ibn.fm/SKpsT About Genprex Inc. Genprex is a…

Continue Reading

ThursdayDec 03, 2020 12:45 pm

QualityStocksNewsBreaks – Sugarmade Inc. (SGMD) Set to Drive ‘Strong Margins Up and Down the Chain’

Sugarmade (OTCQB: SGMD), a leading, multidivisional/multiproduct/multisector supply company, recently secured rights to a property zoned for cannabis cultivation. The company is well on its way to benefit from this move, already in the process of obtaining cannabis cultivation licensing, preparing archaeological and biological surveys, and assembling documentation related to the architectural and engineering plans for construction of greenhouses and a processing building. “We believe we have all of the strategic pieces in place to capitalize on cultivation, with the market currently chronically undersupplied,” said Sugarmade CEO Jimmy Chan in a recent update. “We also have relationships in place, especially through…

Continue Reading

ThursdayDec 03, 2020 12:31 pm

QualityStocksNewsBreaks – Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) Completes Proof-of-Concept of Modern Lithium Extraction, Crystallisation Technology

Standard Lithium (TSX.V: SLL) (OTCQX: STLHF) (FRA: S5L), an innovative technology and lithium project development company, has completed the start-to-finish proof of concept of its proprietary modern lithium processing technology. The company was successfully able to directly extract lithium from brine and produce a purified, concentrated intermediate product (LiCl solution). In addition, that LiCl solution was converted to better-than-battery quality lithium carbonate product. The solution was produced by STLHF’s first-of-its-kind Direct Lithium Extraction (“DLE”) demonstration plant and then transferred to the company’s SiFT Pilot Plant in British Columbia for conversion. The final result — a high-purity lithium carbonate — was…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered